Press Releases

BOTHELL, WA – December 20, 2010 – SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, said today that Kevin M. Goodwin, SonoSite’s President and CEO, will present at the 29th Annual JP Morgan Healthcare Conference being held at the Westin St. Francis Hotel in San Francisco, January 10-13, 2011.

The session will be webcast live on Wednesday, January 12, 2011 at 9:30 am Pacific Time. An audio replay will be available for 30 days following and can be accessed via SonoSite’s website at www.sonosite.com/investorinformation/webcasts .

About SonoSite SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

US Sector Achieves an All Time High in Quarterly Revenues of $40 Million, Up 35% VisualSonics (VSI) Acquisition Delivers Second Consecutive Strong Quarter Company Experienced Improving Momentum and Market Dynamics

BOTHELL, WA – January 10, 2011 – SonoSite, Inc. (Nasdaq: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced preliminary revenue results for the fourth quarter and year ended December 31, 2010.

Revenue for the fourth quarter was approximately $89 million, an increase of 27% for the quarter. Full-year 2010 revenue reached $275 million compared to $227 million in 2009, an increase of 21%.

VisualSonics revenue was $8.8 million for the quarter, representing the second consecutive strong performance since the company was acquired in June 2010.

SonoSite revenue, excluding VSI, was approximately $80 million, an increase of 15% compared to the fourth quarter of 2009, and $257 million for the full-year, an increase of 13%.

BOTHELL, WA - December 20, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, said today that Kevin M. Goodwin, SonoSite’s President and CEO, will present at the 29th Annual JP Morgan Healthcare Conference being held at the Westin St. Francis Hotel in San Francisco, January 10-13, 2011.

The session will be webcast live on Wednesday, January 12, 2011 at 9:30 am Pacific Time. An audio replay will be available for 30 days following and can be accessed via SonoSite’s website at www.sonosite.com/investorinformation/webcasts .

About SonoSite SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

US Revenue Up 17% International Revenue Up 7% VisualSonics Revenue Up 30% Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern

BOTHELL, WA - October 21, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today reported financial results for the third quarter and nine months ended September 30, 2010.

REVENUE Revenue increased 28% in the third quarter to $68.5 million and increased 18% for the nine months of 2010 to $186.1 million, as compared to the prior year.

Revenue included $8.7 million for the third quarter and nine months from the recently acquired VisualSonics (VSI).

Excluding VSI, revenue in the third quarter was $59.8 million, an increase of 12% compared to the third quarter of 2009, and $177.4 million, an increase of 12% for the nine months just ended.

Revolutionary portable technology provides dynamic assessment of soft tissue and bone injuries

BOTHELL, WA - October 21, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, and the National Basketball Association (NBA), announced today a multiyear agreement to introduce SonoSite's ultrasound technology to the NBA's medical and athletic training professionals.

As part of the agreement, SonoSite will be the preferred provider of ultrasound products to the NBA and the NBA Development League (NBA D-League). This relationship will educate the NBA and NBA D-League's team physicians and athletic trainers about SonoSite's unique diagnostic ultrasound tools that are highly portable and can assist in efficiently diagnosing, treating, and monitoring the rehabilitation of professional athletes.

BOTHELL, WA - October 14, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that its latest breakthrough in ultrasound imaging, Advanced Needle Visualization, will be featured at the American Society of Anesthesiologists 2010 Annual Meeting. This technology was first introduced in July 2010 and is a proprietary imaging algorithm that intensifies the brightness of the needle, making it clearly visible during a steep angle nerve block approach for deep targets, conditions under which the needle has previously been very difficult to image. The conference is being held in San Diego, California at the San Diego Convention Center, October 16-18, 2010

As a solution for the "lost needle phenomenon," which has been a well-known limitation in ultrasound needle imaging, anesthesiologists worldwide have quickly responded to Advanced Needle Visualization as a key tool for saving time, and improving patient safety. The algorithm enables physicians to increase confidence through visualization of the needle, which may result in less procedure time while maintaining fully-diagnostic image quality from near to far field, preserving anatomical detail.

BOTHELL, WA - October 7, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, announced today that it will report the company's third quarter financial results on Thursday, October 21, 2010 at the close of market and will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on that day. The call will be broadcast live and can be accessed via SonoSite’s website at www.sonosite.com/investorinformation/webcasts .

A replay of the audio webcast will be available beginning October 21, 2010 at 5:30 p.m. PT and can be accessed until November 4, 2010 at 9:59 p.m. PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 7304277 is required to access the replay. Additionally, the call will be archived on SonoSite’s website.

About SonoSite SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

BOTHELL, WA - September 2, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, said today that Kevin M. Goodwin, SonoSite's President and CEO, will present at the Stifel Nicolaus Healthcare Conference being held at the Four Seasons Hotel in Boston from September 15-17, 2010.

The session will be webcast live on Wednesday, September 15 at 11:30 am, Eastern Time. An audio replay will be available for 30 days following and can be accessed via SonoSite's website at www.sonosite.com/investorinformation/webcasts .

About SonoSite SonoSite, Inc. ( www.sonosite.com ) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. SonoSite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

First Generation Product Provides Unique Tracking and Guidance Technology for PICC Line Procedures

BOTHELL, WA - August 26, 2010 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, announced today that it received FDA clearance for its innovative LumenVu® Catheter Guidance System. Designed to aid in the placement of peripherally inserted central catheters (PICC), the proprietary LumenVu System combines near-infrared technology with a revolutionary fiber optic stylet, which replaces a traditional guide wire, to allow visualization and real-time tracking of a catheter tip as it advances through a vein.

"Receiving FDA clearance is an important milestone in the strategic development and global commercialization of the LumenVu System and it reinforces our dedication to providing patients with improved safety and health," said Kevin M. Goodwin, SonoSite's President and CEO.

"We envision this technology ultimately advancing beyond PICC line placements and potentially into a broader range of clinical applications. This clearance also represents a significant step towards the development of a fully integrated line placement imaging solution, which will include ultrasound visualization."

Mr. Cramer Will Remain on the Board as Chairman Emeritus Through the End of His Term in April 2011 SonoSite's Board Adopts a Smaller and More Simplified Structure for 2011

BOTHELL, WA - August 12, 2010 - SonoSite, Inc. (Nasdaq: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced that Kirby L. Cramer is retiring as non-executive Chairman of the Board of Directors, effective August 12, 2010. As part of the Board's succession plan, Mr. Cramer will continue to serve as a director until SonoSite's 2011 annual meeting of shareholders. SonoSite's Board is naming Robert G. Hauser, M.D., F.A.C.C., F.H.R.S. to serve as non-executive Chairman of the Board. Mr. Cramer and Dr. Hauser will begin working together to create an orderly transition process over the next several weeks.

TRUSTED ADVISOR FOR TWELVE YEARS